Mobile

Study to compare on-demand treatment to a prophylaxis regimen of BeneFIX in Hemophilia B subjects with a Factor IX activity:≤2%

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-000520-15

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to demonstrate that a prophylaxis regimen of BeneFIX reduces the ABR compared to on demand treatment in subjects with moderately severe to severe hemophilia B.

Critère d'inclusion

  • Hemophilia B

Liens